Biogen Pharma

  • Market Cap: Micro Cap
  • Industry: Non Banking Financial Company (NBFC)
  • ISIN: INE703D01023
  • NSEID:
  • BSEID: 531752
INR
0.29
0.00 (0.00%)
BSENSE

Nov 20

BSE+NSE Vol: 25.92 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 200854,
    "name": "Biogen Pharma",
    "stock_name": "Biogen Pharma",
    "full_name": "Biogen Pharmachem Industries Ltd",
    "name_url": "stocks-analysis/biogen-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "0.29",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "0.29",
    "mcapval": "31.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531752,
    "symbol": "",
    "ind_name": "Non Banking Financial Company (NBFC)",
    "ind_code": 49,
    "indexname": "",
    "isin": "INE703D01023",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "25.92 lacs",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/biogen-pharma-200854-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Biogen Pharmachem Industries Ltd Valuation Shifts Signal Elevated Price Risk",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/biogen-pharmachem-industries-ltd-valuation-shifts-signal-elevated-price-risk-4251113",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/BiogenPharmache_valuationdot_4251113.png",
        "date": "2026-11-05 08:00:30",
        "description": "Biogen Pharmachem Industries Ltd, a micro-cap player in the Non Banking Financial Company (NBFC) sector, has seen its valuation parameters deteriorate sharply, moving from a 'risky' to a 'very expensive' rating. With a price-to-earnings (P/E) ratio soaring to 45.39 and a price-to-book value (P/BV) of just 0.27, investors face a complex valuation landscape amid weak returns and negative capital employed metrics."
      },
      {
        "title": "Biogen Pharmachem Industries Ltd Falls to 52-Week Low of Rs 0.24 as Sell-Off Deepens",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/biogen-pharmachem-industries-ltd-falls-to-52-week-low-of-rs024-4226261",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/BiogenPharmache_priceRelatedfactors_4226261.png",
        "date": "2026-10-15 09:40:36",
        "description": "For the second consecutive session, Biogen Pharmachem Industries Ltd has seen its share price decline further, hitting a fresh 52-week low of Rs 0.24 on 15 Oct 2026. This drop extends the stock’s year-long slide, which now stands at a steep 64.79% loss, significantly underperforming the Sensex’s 11.24% decline over the same period."
      },
      {
        "title": "Biogen Pharmachem Industries Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/biogen-pharmachem-industries-ltd-is-rated-strong-sell-4218783",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/BiogenPharmache_mojoScore_4218783.png",
        "date": "2026-10-08 10:10:27",
        "description": "Biogen Pharmachem Industries Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 September 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 08 October 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Markets Rally, But Biogen Pharmachem Industries Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/biogen-pharmachem-industries-ltd-falls-to-52-week-low-of-rs025-4190025",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BiogenPharmache_priceRelatedfactors_4190025.png",
        "date": "2026-09-11 09:36:18",
        "description": "Despite a broadly positive market environment, Biogen Pharmachem Industries Ltd has plunged to a fresh 52-week low of Rs 0.25 on 11 Sep 2026, marking a steep 64.94% decline over the past year and underperforming the Sensex by a wide margin."
      }
    ],
    "total": 43,
    "sid": "200854",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/biogen-pharmachem-industries-200854"
  },
  "announcements": [
    {
      "caption": "Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015",
      "datetime": "03-Nov-2026",
      "details": "PFA",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 03Rd November 2026.",
      "datetime": "03-Nov-2026",
      "details": "Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the Board of Directors of the Company in their meeting held on today i.e. Tuesday 03rd November 2026. at the Registered Office of the Company and transacted the following major businesses:",
      "source": "BSE"
    },
    {
      "caption": "Regulation 33 Read With Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (\"Listing Regulations\")",
      "datetime": "03-Nov-2026",
      "details": "PFA",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Biogen Pharmachem Industries Ltd has announced <strong>1:6</strong> bonus issue, ex-date: 15 May 26",
          "dt": "2026-05-15",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015

03-Nov-2026 | Source : BSE

PFA

Board Meeting Outcome for Outcome Of Board Meeting Held On 03Rd November 2026.

03-Nov-2026 | Source : BSE

Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the Board of Directors of the Company in their meeting held on today i.e. Tuesday 03rd November 2026. at the Registered Office of the Company and transacted the following major businesses:

Regulation 33 Read With Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ("Listing Regulations")

03-Nov-2026 | Source : BSE

PFA

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

Biogen Pharmachem Industries Ltd has announced 1:6 bonus issue, ex-date: 15 May 26

stock-summary
RIGHTS

No Rights history available